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CAS CLINIQUE | CASE REPORT

Médecine orale/Oral Medecine

FIELD CANCERIZATION OF ORAL CAVITY:
A CASE REPORT AND ITS CLINICAL IMPLICATIONS
Raghavendra Kini* Vathsala Naik** Smit Singla***
Abstract
In 1953, Slaughter et al. proposed the concept of field cancerization when studying the presence of histologically abnormal tissue
surrounding oral squamous cell carcinoma. It was observed that all of the epithelium beyond the boundaries of tumor is submitted to
histological changes and were found to have more than one independent area of malignancy. In conclusion, the mucosa undergoes
a change, perhaps due to carcinogen exposure and is therefore more susceptible to the development of many foci of malignant
transformation. These observations help to explain the high incidence of recurrence, despite excision of tumor or other therapies. So,
diagnosis and treatment of oral cancer should not only be focused on the lesion, but also on the field from which it developed. In this
article, we emphasize on the concept of field cancerization, its clinical implications by presenting a clinical case.
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CANCÉRISATION DE CHAMP DE LA CAVITÉ BUCCALE. À PROPOS
D’UN CAS CLINIQUE ET SES IMPLICATIONS CLINIQUES
Résumé
En 1953, Slaughter et coll. ont proposé le concept de champ de cancérisation en étudiant la présence, à l’échelle histologique, de
cellules anormales entourant le carcinome épidermoïde. Il a été observé que tout l’épithélium au-delà des frontières de la tumeur
présentait des changements histologiques, en plus d’une zone indépendante libre de malignité. En conclusion, l’épithélium subit un
changement, peut être en raison de l’exposition à des substances cancérigènes et devient donc plus propice au développement de
plusieurs foyers de transformation maligne. Ces observations aident à expliquer la haute incidence de récidive, malgré l’excision
tumorale associée ou non à d’autres thérapies. Le diagnostic et le traitement du cancer oral devraient être établis, non seulement
au niveau de la lésion, mais aussi au niveau du champ à partir duquel il s’est développé. A travers cet article, nous soulignerons
l’importance du concept de champ de cancérisation et ses implications cliniques, par la présentation d’un cas.
Mots clés: champ de cancérisation - carcinome épidermoïde - leucoplasie - dysplasie.
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Introduction
Oral cavity is one of the prevalent
sites for the development of pre-malignant diseases. It is well known that
these pre-malignant pathologies may
progress to dysplastic lesions then
to invasive carcinomas. Field cancerization is a well known and well documented process of malignant transformation. The term “field cancerization”
was proposed by Slaughter et al. [1]
in 1953, when studying oral cancer.
The term field cancerization has been,
since then, utilized to explain the followings: (a) oral cancer developing
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in multifocal areas of a precancerous
change; (b) abnormal tissues surrounding the tumor; (c) oral cancer often
consisting of multiple independent
lesions that may coalesce; (d) the persistence of abnormal tissue even after
surgery may explain secondary primary
tumor and recurrences [2].

right molar region since 2 months.
The growth was insidious in onset
and gradually increased in size. Since
the first week, the growth was associated with localized, severe and throbbing pain. Intake of hot and spicy food
caused severe burning sensation. Past
dental and medical histories were noncontributory, even though reporting
some weight loss. The patient had the
habit of chewing beeda (a combination
of betel leaves, betel nut, tobacco and
slaked lime) 4-5 times a day for the
past 12 years.
On extraoral examination, there
was no gross facial asymmetry. A soli-

Case report
A 78 year old female patient presented to the Department of Oral
Medicine and Radiology of A.J. Institute
of Dental Sciences, Mangalore, with
a complaint of growth in the lower

37
Médecine orale/Oral Medecine

Fig.l: Ulceroproliferative lesion in right
retromolar area.

tary submandibular lymph node was
palpable on the right side, measuring
1.5 cm in size, tender, firm in consistency and freely movable.
Intraorally, an ulcero-proliferative
lesion was evident on right retromolar area, measuring about 3.5x2.5 cm
in size. It was irregular in shape with
rolled out edges. The centre of the
lesion was composed of whitish-yellow slough (Fig.1). The lesion was tender on palpation with indurated base.
The first molar was mobile (grade II),
second and third molars were missing.
On left buccal mucosa, an elevated
white patch was present at the level
of maxillary second and third molars,
measuring about 1.5 cm in size. The
surface was white, with multiple red
pin sized papules. The lesion wasn’t
tender on palpation (Fig.2).
The surrounding mucosa was blanched and opaque. Buccal mucosa of
either side had lost its normal elasticity and was leathery in consistency.
Multiple fibrous bands were palpable
on both right and left buccal mucosa.
The tongue was smooth and shiny and
its movements were restricted (Fig.3).
A provisional diagnosis of carcinoma of right retromolar area (T1N1M0),
speckled leukoplakia on the left buccal
mucosa and oral submucous fibrosis
were made. Before undertaking biopsy,
routine blood investigations were car-

Fig.2: Speckeled leukoplakic lesion on left
buccal mucosa.

ried out; the parameters were well
within normal limits.
Radiographic survey of the skeleton and ultrasonography of the abdomen were done to rule out distant
metastasis. Incisional biopsy of the
lesion on right retromolar area and
excisional biopsy of the lesion on the
left buccal mucosa were undertaken.
Biopsy specimen revealed discontinuity in the basement membrane with
dysplastic epithelial cells invading
connective tissue and islands with keratin pearls. Individual tumor epithelial
cells showed various degrees of pleomorphism, suggesting moderately differentiated squamous cell carcinoma,
whereas the biopsy specimen from the
left buccal mucosa revealed mild to
moderate epithelial dysplasia.
Orthopantomograph, C.T. (Fig.4)
didn’t show any bone erosion.
Ultrasound of the neck revealed involvement of upper jugular lymph nodes
measuring 15 mm on the right side and
10 mm on the left side.
Wide excision of the lesion and
modified radical neck dissection with
reconstruction using pectoralis major
myocutaneous flap were realised
(Fig.5). Patient is currently undergoing
treatment for oral submucous fibrosis and is under regular follow-up to
detect any local relapse or formation
of any secondary primary tumors.

Fig.3: Shiny and smooth tongue.

Discussion
In field cancerization, an area of
epithelium has been preconditioned
by long term exposure to carcinogens.
In this preconditioned epithelium,
multifocal carcinomas can develop as
a result of independent mutations and
this would not be genetically related.
Thus, the carcinoma occurs from
multifocal areas of precancerous
change and not from one cell that suddenly becomes malignant. It is well
accepted that the progression from
normal to cancer cell is a multistep
process in carcinogenesis [3, 4]. It
would also explain, in part, the high
recurrence rate in oral carcinoma after
surgery or radiation therapy. In case of
surgery, the margins seldom extended
beyond the limits of abnormal epi-
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Fig.4: No bony involvement on the C.T.

thelium, whereas radiation therapy is
less effective on the benign epithelium
and leukoplakia than on cancer cells.
However, Rennemo et al. [5] observed
lower incidence of secondary primary
tumors in irradiated patients, suggesting preventive effect of radiation on
malignant transplantation of subclinic
premalignant foci.
The recurrence may be due to
changes toward cancer of a benign,
preconditioned epithelium, which
have been opposed in a suture line,
after excision of a tumor, or has healed over the site of a tumor destroyed
by radiation. Many recent studies have
shown the presence of altered fields of
mucosa remaining beyond the limits
of resection, both on histopathological
and on molecular basis [6].
The criteria used to diagnose multiple primary carcinomas, as originally
described by Warren and Gates [7] and
modified by Hong et al. [8] were as
follows:
1- Each neoplasm must be anatomically separate and distinct (if the
intervening mucosa demonstrates dysplasia, it is considered a multicentric
primary neoplasm).
2- The possibility that the second
primary carcinoma represents a
metastasis or a local relapse must be
excluded. It has to be separated from
the first by at least 2 cm of normal epithelium or has to occur at least 3 years
after the first diagnosis.

Fig.5: Post-operative 10 days after surgery.

A number of parameters can determine whether a field develops into
a new tumor. A very important factor
might be the follow-up period, since a
premalignant field may need a longer
time to progress into a new tumor than
a tumor that develops from remaining
tumor cells. Meo et al. [9] and Rosin
et al. [10] have reported that oral premalignant lesions might need up to 67
or 96 months, respectively, to progress
into invasive carcinoma.

Clinical implications
The presence of a field with genetically altered cells is a risk factor for cancer. The large number of preneoplastic
cells in the proliferating fields is likely
to increase cancer risk dramatically.
The probability of developing a
second primary tumor in a patient who
once had head and neck squamous
cell cancer is around 20% [11].
Cancer begins with multiple cumulative epigenetic and genetic alterations, leading to sequential cellular
transformations. The early genetic
events might lead to clonal expansion of pre-malignant daughter cells
in a particular tumor field. Subsequent
genomic changes in some of these
cells drive them toward the malignant
phenotype. Histologically, these transformed cells are diagnosed as cancer
owing to alterations in their morphology. Thus, a population of daugh-

ter cells with early genetic changes
(without
histological
changes)
remains in the organ, demonstrating
the concept of field cancerization
[12]. For early detection of a cancer,
one can rely on tumor markers. But
what is important, in the context of
field cancerization, is identification of
molecular signatures in the genetically
transformed but histologically normal
cells (peri-tumoral cancer field). So,
identification of such tumor specific
biomarkers will have excellent utility
in monitoring the tumor progression
and if possible, in preventing transformation of pre-malignant lesions into
invasive cancer.

Conclusion
The presence of a field with genetically altered cells is a risk factor for
cancer. A good research in this field
has a strong potential to reveal new
diagnostic markers for early detection,
modalities to prevent progression, and
lastly ways to combat development of
second primary tumor (or second field
tumors).
Finally, not only early detection
and management of oral cancer are
important, but equally important are
early identification and management
of a field, so as to have profound implications on cancer prevention and outcome of the treatment.
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